Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.4932 USD
−73.63 M USD
805.11 K USD
36.57 M
About Barinthus Biotherapeutics plc
Sector
CEO
William Enright
Headquarters
Didcot
Website
Founded
2021
FIGI
BBG00ZZPCP09
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.